You are here: Industry Insights > PLI

News List

India lags behind in terms of commercially-oriented innovation, R&D and discovery of drug modules expresspharma
August 13, 2021
Established in 1977 by G V Masurkar, ENTOD is one of the fastest growing pharmaceutical companies in the Ophthalmic ENT segment in different markets around the world, with over forty years of specialised expertise in product development and manufacturing.
Achieving Aatmanirbharta in APIs: Are we on the right track? expresspharma
August 03, 2021
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats.
PHDCCI urges government to extend support for vaccine industry expresspharma
June 18, 2021
Industry body PHD Chamber of Commerce and Industry (PHDCCI) has urged the government to play an enabler’s role for the vaccine sector, and sought clarity on the status of the segment under the ambit of the production-linked incentive (PLI) scheme ...
PLI scheme to help India become Aatmanirbhar in APIs; boost investments in high-value generics: ICRA expresspharma
June 18, 2021
The production-linked incentive (PLI) schemes announced by the Government of India (GoI) for key raw materials such as bulk drugs and formulations, with a total incentive outlay of Rs. 210 billion will help the country become Aatmanirbhar.
Government issues operational guidelines for pharma PLI scheme expresspharma
June 03, 2021
The applications are invited in the three groups based on the Global Manufacturing Revenue of FY 2019-20 of the applicant. A special carve-out for MSMEs has been kept under the scheme.
Four pharma firms get approval under PLI scheme for bulk drugs expresspharma
June 01, 2021
The government has given approval to four waitlisted firms under the Production Linked Incentive (PLI) scheme for domestic manufacturing of bulk drugs, an official statement said.
Pharma firms with approval for projects under PLI scheme should start production at the earliest: Gowda expresspharma
April 22, 2021
This will enable India to provide pharma and medical devices products to domestic and global markets at competitive rates.
Govt. set to introduce single-window clearance for investors by Apr15: DPIIT Secy expresspharma
March 26, 2021
The single-window portal will integrate the existing clearance systems of various central and state departments.
Aarti Speciality Chemicals gets approval under Pharma PLI Scheme expresspharma
March 08, 2021
The approval is for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum under Target Segment III (Key Chemical Synthesis Based KSMs/Drug Intermediates).
Industry welcomes PLI 2.0 Scheme, awaits implementation details expresspharma
February 26, 2021
Stakeholders highlight that this scheme will help play to our strengths, work towards making the pharma industry more self-reliant, generate employment and usher more affordability in healthcare.

Previous page 1 2 Next page